Image-guided ablation of hepatocellular carcinoma

Interventional Oncology: Principles and Practice

Volumn , Issue , 2008, Pages 145-159

  Lencioni, Riccardo ^a   Crocetti, Laura ^a   Pina, Clotilde Della ^a   Cioni, Dania ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84932649760     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511722226.015     Document Type: Chapter

References (70)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
2. Sherman M. Hepatocellular carcinoma: Epidemiology, risk factors, and screening. Semin Liver Dis 2005; 25: 143-154.
3. Lencioni R, Cioni D, Della Pina C, et al. Imaging diagnosis. Semin Liver Dis 2005; 25: 162-170.
4. Bruix J, Boix L, Sala M, et al. Focus on hepatocellular carcinoma. Cancer Cell 2004; 5: 215-219.
5. Bruix J, Sherman M, Llovet JM, et al.; EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma: Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430.
6. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
7. KojiroM, RoskamsT. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 2005; 25: 133-142.
8. Levy I, Greig PD, Gallinger S, et al. Resection of hepatocellular carcinoma without preoperative tumor biopsy. Ann Surg 2001; 234: 206-209.
9. Johnson PJ. Hepatocellular carcinoma: Is current therapy really altering outcome? Gut 2002; 51: 459-462.
10. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: TheBCLCstaging classification. Semin Liver Dis 1999; 19: 329-338.
11. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 1999; 30: 1434-1440.
12. Fong Y, Sun RL, Jarnagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790-800.
13. Wayne JD, Lauwers GY, Ikai I, et al. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 2002; 235: 722-731.
14. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25: 181-200.
15. Jonas S, Beckstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantion for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-1086.
16. Yao FY, Ferrel L, BassNM, et al. Liver transplantation for hepatocellular carcinoma: Expansion of tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403.
17. Yao FY, Bass NM, Nikolai B, et al. Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002; 8: 873-883.
18. Lencioni R, Bartolozzi C, Caramella D, et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: Analysis of prognostic factors in 105Western patients. Cancer 1995; 76: 1737-1746.
19. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101-108.
20. Ryu M, Shimamura Y, Kinoshita T, et al. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: A retrospective multicenter study. Jpn J Clin Oncol 1997; 27: 251-257.
21. Lencioni R, Pinto F, Armillotta N, et al. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: A European experience. Eur Radiol 1997; 7: 514-519.
22. Teratani T, Ishikawa T, Shiratori Y, et al. Hepatocellular carcinoma in elderly patients: Beneficial therapeutic efficacy using percutaneous ethanol injection therapy. Cancer 2002; 95: 816-823.
23. Ebara M, Okabe S, Kita K, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: Therapeutic efficacy based on 20-year observation. J Hepatol 2005; 43: 458-464.
24. Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993; 18: 1121-1126.
25. Yamamoto J, Okada S, Shimada K, et al. Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001; 34: 707-713.
26. Daniele B, De Sio I, Izzo F, et al., CLIP Investigators. Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: ACancer of the Liver Italian Program (CLIP 08) retrospective casecontrol study. J Clin Gastroenterol 2003; 36: 63-67.
27. Di Stasi M, Buscarini L, Livraghi T, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma: A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 1997; 32: 1168-1173.
28. Khan KN, Yatsuhashi H, Yamasaki K, et al. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 2000; 32: 269-278.
29. Koda M, Murawaki Y, Mitsuda A, et al. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000; 88: 529-537.
30. Livraghi T, Benedini V, Lazzaroni S, et al. Long-term results of single-session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 1998; 83: 48-57.
31. Ohnishi K, Yoshioka H, Ito S, et al. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998; 27: 67-72.
32. Huo TI, Huang YH, Wu JC, et al. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: Aprospective study. Scand J Gastroenterol 2003; 38: 770-778.
33. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancies: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174: 323-331.
34. Dodd GD 3rd, Frank MS, Aribandi M, et al. Radiofrequency thermal ablation: Computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol 2001; 177: 777-782.
35. Goldberg SN, Charboneau JW, Dodd GD 3rd, et al; International Working Group on Image-guided Tumor Ablation. Image-guided tumor ablation: Proposal for standardization of terms and reporting criteria. Radiology 2003; 228: 335-345.
36. Lencioni R, Crocetti L. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Clin Liver Dis 2005; 9: 301-314.
37. Lu DS, Yu NC, Raman SS, et al. Radiofrequency ablation of hepatocellular carcinoma: Treatment success as defined by histologic examination of the explanted liver. Radiology 2005; 234: 954-960.
38. Lencioni R, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240.
39. Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma≤4 cm. Gastroenterology 2004; 127: 1714-1723.
40. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation versus ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-130.
41. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961-967.
42. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. Cancer 2005; 103: 1201-1209.
43. Cabassa P, Donato F, Simeone F, et al. Radiofrequency ablation of hepatocellular carcinoma: Long-term experience with expandable needle electrodes. AmJ Roentgenol 2006; 185: S316-321.
44. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: Long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007; 17: 684-692.
45. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243: 321-328.
46. Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging 2005; 30: 409-418.
47. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications encountered in a multicenter study. Radiology 2003; 26: 441-451.
48. De Baere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003; 181: 695-700.
49. Bleicher RJ, Allegra DP, Nora DT, et al. Radiofrequency ablation in 447 complex unresectable liver tumors: Lessons learned. Ann Surg Oncol 2003; 10: 52-58.
50. Llovet JM, Vilana R, Bru C, et al; Barcelona Clinic Liver Cancer (BCLC) Group. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33: 1124-1129.
51. Fontana RJ, Hamidullah H, Nghiem H, et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: A safe and effective bridge to liver transplantation. Liver Transpl 2002; 8: 1165-1174.
52. Wong LL, Tanaka K, Lau L, et al. Pre-transplant treatment of hepatocellular carcinoma: Assessment of tumor necrosis in explanted livers. Clin Transplant 2004; 18: 227-234.
53. Lencioni R, Cioni D, Crocetti L, et al. Percutaneous ablation of hepatocellular carcinoma: State-of-the-art. Liver Transpl 2004; 10: S91-97.
54. Lu DS, Yu NC, Raman SS, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005; 41: 1130-1137.
55. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217: 119-126.
56. Yamasaki T, Kurokawa F, Shirahashi H, et al. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow: Comparison with standard percutaneous radiofrequency ablation therapy. Cancer 2002; 95: 2353-2360.
57. Kitamoto M, Imagawa M, Yamada H, et al. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: Comparison of the radiofrequency effect with and without chemoembolization. Am J Roentgenol 2003; 181: 997-1003.
58. Lencioni R, Della Pina C, Bartolozzi C. Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma. Abdom Imaging 2005; 30: 401-408.
59. Veltri A, Moretto P, Doriguzzi A, et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE)as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 2006; 16: 661-669.
60. Lu MD, Chen JW, Xie XY, et al. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 2001; 221: 167-172.
61. Yamashiki N, Kato T, Bejarano PA, et al. Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: Review of 15 explanted livers. Am J Gastroenterol 2003; 98: 2052-2059.
62. Yu NC, Lu DS, Raman SS, et al. Hepatocellular carcinoma: Microwave ablation with multiple straight and loop antenna clusters-pilot comparison with pathologic findings. Radiology 2006; 239: 269-275.
63. Seki T, Wakabayashi M, Nakagawa T, et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: Comparison with percutaneous ethanol injection therapy. Cancer 1999; 85: 1694-1702.
64. Dong B, Liang P, Yu X, et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: Results in 234 patients. Am J Roentgenol 2003; 180: 1547-1541.
65. Liang P, Dong B, Yu X, et al. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005; 235: 299-307.
66. Shibata T, Iimuro Y, Yamamoto Y, et al. Small hepatocellular carcinoma: Comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223: 331-337.
67. Vogl TJ, Muller PK, Hammerstingl R, et al. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: Technique and prospective results. Radiology 1995; 196: 257-265.
68. Pacella CM, Bizzarri G, Magnolfi F, et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma: Results in 74 patients. Radiology 2001; 221: 712-720.
69. Vogl TJ, Straub R, Eichler K, et al. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: Experience with complications in 899 patients (2, 520 lesions). Radiology 2002; 225: 367-377.
70. Lencioni R, Della Pina C, Crocetti L, et al. Percutaneous ablation of hepatocellular carcinoma. Recent Results Cancer Res 2006; 167: 91-105.